CMS says CGMs cannot be used with other technology

 - 
Thursday, March 30, 2017

WASHINGTON – Medicare beneficiaries using Dexcom’s G5 Mobile continuous glucose monitoring system cannot use smartphone apps or tablets to display glucose data if they want to have the CGM device reimbursed, according to recently released guidance from CMS. If a beneficiary uses a non-DME device (smart phone, tablet, etc.) as the display device, either separately or in combination with the CGM receiver classified as DME, the supply allowance is non-covered. CMS in January said it would classify certain CGMs as DME. Currently, only the Dexcom G5 meets criteria.